CRYO-CELL INTERNATIONAL, INC. Notes Payable, Current
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Notes Payable, Current of $195.13 thousand as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2026-07-15
- 2026-05-31: Notes Payable, Current $195.13K.
- 2026-02-28: Notes Payable, Current $191.09K.
- 2025-11-30: Notes Payable, Current $183.65K.
- 2025-08-31: Notes Payable, Current $179.19K.
| Period end | Notes Payable, Current |
|---|---|
| 2026-05-31 | $195.13K 10-Q · filed 2026-07-15 |
| 2026-02-28 | $191.09K 10-Q · filed 2026-04-14 |
| 2025-11-30 | $183.65K 10-Q · filed 2026-07-15 |
| 2025-08-31 | $179.19K 10-Q · filed 2025-10-15 |
| 2025-05-31 | $177.60K 10-Q · filed 2025-07-15 |
| 2025-02-28 | $178.79K 10-Q · filed 2025-04-14 |
| 2024-11-30 | $170.49K 10-K · filed 2026-02-27 |
| 2024-08-31 | $174.59K 10-Q · filed 2024-10-15 |
| 2024-05-31 | $171.60K 10-Q · filed 2024-07-15 |
| 2024-02-29 | $168.62K 10-Q · filed 2024-04-15 |
| 2023-11-30 | $165.64K 10-K · filed 2025-02-28 |
| 2023-08-31 | $162.66K 10-Q · filed 2023-10-12 |
| 2023-05-31 | $158.46K 10-Q · filed 2023-07-14 |
| 2023-02-28 | $158.46K 10-Q · filed 2023-04-21 |
| 2022-11-30 | $150.53K 10-K · filed 2024-02-28 |
| 2022-08-31 | $154.25K 10-Q · filed 2022-10-18 |
| 2022-05-31 | $357.84K 10-Q · filed 2022-07-11 |
| 2022-02-28 | $1.13M 10-Q · filed 2022-04-13 |
| 2021-11-30 | $1.90M 10-K · filed 2023-02-28 |
| 2021-08-31 | $2.66M 10-Q · filed 2021-10-15 |
| 2021-05-31 | $3.10M 10-Q · filed 2021-07-15 |
| 2021-02-28 | $3.10M 10-Q · filed 2021-04-14 |
| 2020-11-30 | $3.10M 10-K · filed 2022-02-22 |
| 2020-08-31 | $3.10M 10-Q · filed 2020-10-15 |
| 2020-05-31 | $3.10M 10-Q · filed 2020-07-10 |
| 2020-02-29 | $3.10M 10-Q · filed 2020-04-14 |
| 2019-11-30 | $3.10M 10-K · filed 2021-03-01 |
| 2019-08-31 | $3.10M 10-Q · filed 2019-10-15 |
| 2019-05-31 | $3.10M 10-Q · filed 2019-07-15 |
| 2019-02-28 | $3.10M 10-Q · filed 2019-04-15 |
| 2018-11-30 | $3.10M 10-K · filed 2020-02-28 |
| 2018-08-31 | $3.10M 10-Q · filed 2018-10-15 |
| 2018-05-31 | $2.00M 10-Q · filed 2018-07-16 |
| 2018-02-28 | $2.00M 10-Q · filed 2018-04-16 |
| 2017-11-30 | $2.00M 10-K · filed 2019-02-28 |
| 2017-08-31 | $2.00M 10-Q · filed 2017-10-16 |
| 2017-05-31 | $2.00M 10-Q · filed 2017-07-07 |
| 2017-02-28 | $2.00M 10-Q · filed 2017-04-13 |
| 2016-11-30 | $2.00M 10-K · filed 2018-02-28 |
| 2016-08-31 | $2.00M 10-Q · filed 2016-10-17 |
| 2016-02-29 | $309.99K 10-Q · filed 2016-04-14 |
| 2015-11-30 | $307.42K 10-K · filed 2017-02-28 |
| 2015-08-31 | $303.61K 10-Q · filed 2015-10-15 |
| 2012-08-31 | $194.00K 10-Q · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |